COVID-19 infection for metabolic abnormal human beings

Abstract

The outbreak of coronavirus (COVID-19, SARS-Co-2) infects different kinds of people in the world. The understanding pathogenesis for different kinds of COVID-19 infected people is still investigating. Many key pathways associated with treatment and recovery should be known as clearer as possible. Some lines of clinical evidence and therapeutic association should be noted. Genetic and molecular basis of obesity and diabetes associated with COVID-19 deserve further attention. This Editorial discusses this important topic.